HBV infection is a major cause of liver cirrhosis and hepatocellular carcinoma. Although HBV infection can be efficiently prevented by vaccination, and treatments are available, to date there is no reliable cure for the >240 million individuals that are chronically infected worldwide. Current treatments can only achieve viral suppression, and lifelong therapy is needed in the majority of infected persons. In the framework of the French National Agency for Research on AIDS and Viral Hepatitis 'HBV Cure' programme, a scientific workshop was held in Paris in June 2014 to define the state-of-the-art and unanswered questions regarding HBV pathobiology, and to develop a concerted strategy towards an HBV cure. This review summarises our current understanding of HBV host-interactions leading to viral persistence, as well as the roadblocks to be overcome to ultimately address unmet medical needs in the treatment of chronic HBV infection.

Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure / Mb, Zeisel; J., Lucifora; Ws, Mason; C., Sureau; J., Beck; Levrero, Massimo; M., Kann; Pa, Knolle; M., Benkirane; D., Durantel; Ml, Michel; B., Autran; Fl, Cosset; H., Strick Marchand; C., Trépo; Jh, Kao; F., Carrat; K., Lacombe; Rf, Schinazi; F., Barré Sinoussi; Jf, Delfraissy; F. Zoulim, .. - In: GUT. - ISSN 0017-5749. - STAMPA. - 64:8(2015), pp. ..1314-..1326. [10.1136/gutjnl-2014-308943]

Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure

LEVRERO, Massimo;
2015

Abstract

HBV infection is a major cause of liver cirrhosis and hepatocellular carcinoma. Although HBV infection can be efficiently prevented by vaccination, and treatments are available, to date there is no reliable cure for the >240 million individuals that are chronically infected worldwide. Current treatments can only achieve viral suppression, and lifelong therapy is needed in the majority of infected persons. In the framework of the French National Agency for Research on AIDS and Viral Hepatitis 'HBV Cure' programme, a scientific workshop was held in Paris in June 2014 to define the state-of-the-art and unanswered questions regarding HBV pathobiology, and to develop a concerted strategy towards an HBV cure. This review summarises our current understanding of HBV host-interactions leading to viral persistence, as well as the roadblocks to be overcome to ultimately address unmet medical needs in the treatment of chronic HBV infection.
2015
hepatitis-b-virus; hepatocellular-carcinoma; in-vivo; surface-antigen; humanized mice; molecular determinants; epigenetic regulation; immune-responses; cell-function; viral entry
01 Pubblicazione su rivista::01a Articolo in rivista
Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure / Mb, Zeisel; J., Lucifora; Ws, Mason; C., Sureau; J., Beck; Levrero, Massimo; M., Kann; Pa, Knolle; M., Benkirane; D., Durantel; Ml, Michel; B., Autran; Fl, Cosset; H., Strick Marchand; C., Trépo; Jh, Kao; F., Carrat; K., Lacombe; Rf, Schinazi; F., Barré Sinoussi; Jf, Delfraissy; F. Zoulim, .. - In: GUT. - ISSN 0017-5749. - STAMPA. - 64:8(2015), pp. ..1314-..1326. [10.1136/gutjnl-2014-308943]
File allegati a questo prodotto
File Dimensione Formato  
Zeisel_Towards-An-HBV_2015.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 606.75 kB
Formato Adobe PDF
606.75 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/783761
Citazioni
  • ???jsp.display-item.citation.pmc??? 96
  • Scopus 223
  • ???jsp.display-item.citation.isi??? 203
social impact